GSK's two-drug HIV regimen wins European panel approval
(Reuters) - A panel of European Medicines Agency on Friday recommended approval for GlaxoSmithKline's two-drug regimen to treat HIV, the virus that causes AIDS.
from Reuters: Health News http://reut.rs/2GkDgYE
http://bit.ly/2zwRqiM